Cargando…
In vivo biocompatibility of new nano-calcium-deficient hydroxyapatite/poly-amino acid complex biomaterials
OBJECTIVE: To evaluate the compatibility of novel nano-calcium-deficient hydroxyapatite/poly-amino acid (n-CDHA/PAA) complex biomaterials with muscle and bone tissue in an in vivo model. METHODS: Thirty-two New Zealand white rabbits were used in this study. Biomaterials were surgically implanted int...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4605249/ https://www.ncbi.nlm.nih.gov/pubmed/26504382 http://dx.doi.org/10.2147/IJN.S90273 |
_version_ | 1782395178261151744 |
---|---|
author | Dai, Zhenyu Li, Yue Lu, Weizhong Jiang, Dianming Li, Hong Yan, Yonggang Lv, Guoyu Yang, Aiping |
author_facet | Dai, Zhenyu Li, Yue Lu, Weizhong Jiang, Dianming Li, Hong Yan, Yonggang Lv, Guoyu Yang, Aiping |
author_sort | Dai, Zhenyu |
collection | PubMed |
description | OBJECTIVE: To evaluate the compatibility of novel nano-calcium-deficient hydroxyapatite/poly-amino acid (n-CDHA/PAA) complex biomaterials with muscle and bone tissue in an in vivo model. METHODS: Thirty-two New Zealand white rabbits were used in this study. Biomaterials were surgically implanted into each rabbit in the back erector spinae and in tibia with induced defect. Polyethylene was implanted into rabbits in the control group and n-CDHA/PAA into those of the experimental group. Animals were examined at four different points in time: 2 weeks, 4 weeks, 12 weeks, and 24 weeks after surgery. They were euthanized after embolization. Back erector spinae muscles with the surgical implants were examined after hematoxylin and eosin (HE) staining at these points in time. Tibia bones with the surgical implants were examined by X-ray and scanning electron microscopy (SEM) at these points in time to evaluate the interface of the bone with the implanted biomaterials. Bone tissues were sectioned and subjected to HE, Masson, and toluidine blue staining. RESULTS: HE staining of back erector spinae muscles at 4 weeks, 12 weeks, and 24 weeks after implantation of either n-CDHA/PAA or polyethylene showed disappearance of inflammation and normal arrangement in the peripheral tissue of implant biomaterials; no abnormal staining was observed. At 2 weeks after implantation, X-ray imaging of bone tissue samples in both experimental and control groups showed that the peripheral tissues of the implanted biomaterials were continuous and lacked bone osteolysis, absorption, necrosis, or osteomyelitis. The connection between implanted biomaterials and bone tissue was tight. The results of HE, Masson, toluidine blue staining and SEM confirmed that the implanted biomaterials were closely connected to the bone defect and that no rejection had taken place. The n-CDHA/PAA biomaterials induced differentiation of a large number of chondrocytes. New bone trabecula began to form at 4 weeks after implanting n-CDHA/PAA biomaterials, and lamellar bone gradually formed at 12 weeks and 24 weeks after implantation. Routine blood and kidney function tests showed no significant changes at 2 weeks and 24 weeks after implantation of both biomaterials. CONCLUSION: n-CDHA/PAA composites showed good compatibility in in vivo model. In this study, n-CDHA/PAA were found to be safe, nontoxic, and biologically active in bone repair. |
format | Online Article Text |
id | pubmed-4605249 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-46052492015-10-26 In vivo biocompatibility of new nano-calcium-deficient hydroxyapatite/poly-amino acid complex biomaterials Dai, Zhenyu Li, Yue Lu, Weizhong Jiang, Dianming Li, Hong Yan, Yonggang Lv, Guoyu Yang, Aiping Int J Nanomedicine Original Research OBJECTIVE: To evaluate the compatibility of novel nano-calcium-deficient hydroxyapatite/poly-amino acid (n-CDHA/PAA) complex biomaterials with muscle and bone tissue in an in vivo model. METHODS: Thirty-two New Zealand white rabbits were used in this study. Biomaterials were surgically implanted into each rabbit in the back erector spinae and in tibia with induced defect. Polyethylene was implanted into rabbits in the control group and n-CDHA/PAA into those of the experimental group. Animals were examined at four different points in time: 2 weeks, 4 weeks, 12 weeks, and 24 weeks after surgery. They were euthanized after embolization. Back erector spinae muscles with the surgical implants were examined after hematoxylin and eosin (HE) staining at these points in time. Tibia bones with the surgical implants were examined by X-ray and scanning electron microscopy (SEM) at these points in time to evaluate the interface of the bone with the implanted biomaterials. Bone tissues were sectioned and subjected to HE, Masson, and toluidine blue staining. RESULTS: HE staining of back erector spinae muscles at 4 weeks, 12 weeks, and 24 weeks after implantation of either n-CDHA/PAA or polyethylene showed disappearance of inflammation and normal arrangement in the peripheral tissue of implant biomaterials; no abnormal staining was observed. At 2 weeks after implantation, X-ray imaging of bone tissue samples in both experimental and control groups showed that the peripheral tissues of the implanted biomaterials were continuous and lacked bone osteolysis, absorption, necrosis, or osteomyelitis. The connection between implanted biomaterials and bone tissue was tight. The results of HE, Masson, toluidine blue staining and SEM confirmed that the implanted biomaterials were closely connected to the bone defect and that no rejection had taken place. The n-CDHA/PAA biomaterials induced differentiation of a large number of chondrocytes. New bone trabecula began to form at 4 weeks after implanting n-CDHA/PAA biomaterials, and lamellar bone gradually formed at 12 weeks and 24 weeks after implantation. Routine blood and kidney function tests showed no significant changes at 2 weeks and 24 weeks after implantation of both biomaterials. CONCLUSION: n-CDHA/PAA composites showed good compatibility in in vivo model. In this study, n-CDHA/PAA were found to be safe, nontoxic, and biologically active in bone repair. Dove Medical Press 2015-10-06 /pmc/articles/PMC4605249/ /pubmed/26504382 http://dx.doi.org/10.2147/IJN.S90273 Text en © 2015 Dai et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Original Research Dai, Zhenyu Li, Yue Lu, Weizhong Jiang, Dianming Li, Hong Yan, Yonggang Lv, Guoyu Yang, Aiping In vivo biocompatibility of new nano-calcium-deficient hydroxyapatite/poly-amino acid complex biomaterials |
title | In vivo biocompatibility of new nano-calcium-deficient hydroxyapatite/poly-amino acid complex biomaterials |
title_full | In vivo biocompatibility of new nano-calcium-deficient hydroxyapatite/poly-amino acid complex biomaterials |
title_fullStr | In vivo biocompatibility of new nano-calcium-deficient hydroxyapatite/poly-amino acid complex biomaterials |
title_full_unstemmed | In vivo biocompatibility of new nano-calcium-deficient hydroxyapatite/poly-amino acid complex biomaterials |
title_short | In vivo biocompatibility of new nano-calcium-deficient hydroxyapatite/poly-amino acid complex biomaterials |
title_sort | in vivo biocompatibility of new nano-calcium-deficient hydroxyapatite/poly-amino acid complex biomaterials |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4605249/ https://www.ncbi.nlm.nih.gov/pubmed/26504382 http://dx.doi.org/10.2147/IJN.S90273 |
work_keys_str_mv | AT daizhenyu invivobiocompatibilityofnewnanocalciumdeficienthydroxyapatitepolyaminoacidcomplexbiomaterials AT liyue invivobiocompatibilityofnewnanocalciumdeficienthydroxyapatitepolyaminoacidcomplexbiomaterials AT luweizhong invivobiocompatibilityofnewnanocalciumdeficienthydroxyapatitepolyaminoacidcomplexbiomaterials AT jiangdianming invivobiocompatibilityofnewnanocalciumdeficienthydroxyapatitepolyaminoacidcomplexbiomaterials AT lihong invivobiocompatibilityofnewnanocalciumdeficienthydroxyapatitepolyaminoacidcomplexbiomaterials AT yanyonggang invivobiocompatibilityofnewnanocalciumdeficienthydroxyapatitepolyaminoacidcomplexbiomaterials AT lvguoyu invivobiocompatibilityofnewnanocalciumdeficienthydroxyapatitepolyaminoacidcomplexbiomaterials AT yangaiping invivobiocompatibilityofnewnanocalciumdeficienthydroxyapatitepolyaminoacidcomplexbiomaterials |